1334684-85-3Relevant academic research and scientific papers
PDGFR kinase inhibitor and use thereof
-
Paragraph 0103-0104; 0189-0192, (2021/03/06)
The present invention provides a novel PDGFR kinase inhibitor comprising a compound of formula (I) or a pharmaceutically acceptable salt, solvate, ester, acid, metabolite, or prodrug thereof. The invention also provides a use and a method of the compound of formula (I) for the prevention or treatment of disorders associated with PDGFR kinase activity, in particular for the prevention or treatmentof disorders associated with PDGFR alpha and/or PDGFR beta kinase activity.
B-RAF KINASE INHIBITORS
-
Page/Page column 79; 81, (2011/10/13)
The present invention encompasses compounds of general formula (1) where in the groups R0to R3 and L are defined as in claim 1, which are suitable for the 5 treatment of diseases characterised by excessive or abnormal cell proliferat
